| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.39 | 0.02 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.37 | 0.02 |